Logo do repositório
 
Publicação

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

dc.contributor.authorPonte, Cristina
dc.contributor.authorGrayson, Peter C.
dc.contributor.authorRobson, Joanna C.
dc.contributor.authorSuppiah, Ravi
dc.contributor.authorGribbons, Katherine Bates
dc.contributor.authorJudge, Andrew
dc.contributor.authorCraven, Anthea
dc.contributor.authorKhalid, Sara
dc.contributor.authorHutchings, Andrew
dc.contributor.authorWatts, Richard A.
dc.contributor.authorMerkel, Peter A.
dc.contributor.authorLuqmani, Raashid A.
dc.date.accessioned2022-11-22T12:27:14Z
dc.date.available2022-11-22T12:27:14Z
dc.date.issued2022
dc.description© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.pt_PT
dc.description.abstractObjective: To develop and validate updated classification criteria for giant cell arteritis (GCA). Methods: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in six phases: (1) identification of candidate items, (2) prospective collection of candidate items present at the time of diagnosis, (3) expert panel review of cases, (4) data-driven reduction of candidate items, (5) derivation of a points-based risk classification score in a development data set and (6) validation in an independent data set. Results: The development data set consisted of 518 cases of GCA and 536 comparators. The validation data set consisted of 238 cases of GCA and 213 comparators. Age ≥50 years at diagnosis was an absolute requirement for classification. The final criteria items and weights were as follows: positive temporal artery biopsy or temporal artery halo sign on ultrasound (+5); erythrocyte sedimentation rate ≥50 mm/hour or C reactive protein ≥10 mg/L (+3); sudden visual loss (+3); morning stiffness in shoulders or neck, jaw or tongue claudication, new temporal headache, scalp tenderness, temporal artery abnormality on vascular examination, bilateral axillary involvement on imaging and fluorodeoxyglucose-positron emission tomography activity throughout the aorta (+2 each). A patient could be classified as having GCA with a cumulative score of ≥6 points. When these criteria were tested in the validation data set, the model area under the curve was 0.91 (95% CI 0.88 to 0.94) with a sensitivity of 87.0% (95% CI 82.0% to 91.0%) and specificity of 94.8% (95% CI 91.0% to 97.4%). Conclusion: The 2022 American College of Rheumatology/EULAR GCA classification criteria are now validated for use in clinical research.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationAnn Rheum Dis. 2022 Dec;81(12):1647-1653pt_PT
dc.identifier.doi10.1136/ard-2022-223480pt_PT
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttp://hdl.handle.net/10451/55197
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherBMJ Publishing Grouppt_PT
dc.relation.publisherversionhttps://ard.bmj.com/pt_PT
dc.subjectGiant cell arteritispt_PT
dc.subjectMagnetic resonance imagingpt_PT
dc.subjectSystemic vasculitis.pt_PT
dc.title2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritispt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1653pt_PT
oaire.citation.issue12pt_PT
oaire.citation.startPage1647pt_PT
oaire.citation.titleAnnals of the Rheumatic Diseasespt_PT
oaire.citation.volume81pt_PT
person.familyNamePonte
person.givenNameCristina
person.identifier.ciencia-id3713-901B-4493
person.identifier.orcid0000-0002-3989-1192
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication22483f4f-a4d7-48f5-9fae-cc5ae926528a
relation.isAuthorOfPublication.latestForDiscovery22483f4f-a4d7-48f5-9fae-cc5ae926528a

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
EULAR_giant.pdf
Tamanho:
12.42 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: